435P The AGITG Modulate study: Randomised phase II study testing manipulation of the tumour micro environment (TME) to enable synergy with PD1 inhibitors in microsatellite stable (MSS) metastatic colorectal cancer (mCRC)

https://doi.org/10.1016/j.annonc.2021.08.956Get rights and content
Under an Elsevier user license
open archive

Cited by (0)